1 – 23 of 23
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Computational Evidence Based Perspective on the Plausible Repositioning of Fluoroquinolones for COVID-19 Treatment
(
- Contribution to journal › Article
-
Mark
Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development
(
- Contribution to journal › Article
- 2021
-
Mark
A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process : SARS-CoV-2 Mpro maturation
(
- Contribution to journal › Article
-
Mark
FragMAXapp : Crystallographic fragment-screening data-analysis and project-management system
(
- Contribution to journal › Article
-
Mark
Advanced biotechnology-based therapeutics
2021) p.53-77(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2020
-
Mark
Omics for bioprospecting and drug discovery from bacteria and microalgae
(
- Contribution to journal › Scientific review
-
Mark
Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(39). p.24251-24257(
- Contribution to journal › Article
-
Mark
Applications and Approaches for Three-Dimensional Precision-Cut Lung Slices. Disease Modeling and Drug Discovery
(
- Contribution to journal › Scientific review
- 2019
-
Mark
On-chip crystallization for serial crystallography experiments and on-chip ligand-binding studies
(
- Contribution to journal › Article
- 2017
-
Mark
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(2). p.200-208(
- Contribution to journal › Article
- 2016
-
Mark
Nobel Parasites in the Kingdom of Invertebrates
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Structures of endothiapepsin-fragment complexes from crystallographic fragment screening using a novel, diverse and affordable 96-compound fragment library
(
- Contribution to journal › Article
-
Mark
High-Throughput Crystallography : Reliable and Efficient Identification of Fragment Hits
(
- Contribution to journal › Article
- 2014
-
Mark
Aminooxy analog of histamine is an efficient inhibitor of mammalian l-histidine decarboxylase: combined in silico and experimental evidence
(
- Contribution to journal › Article
- 2013
-
Mark
Discovery and Structural Characterization of a Phospholamban-Binding Cyclic Peptide and Design of Novel Inhibitors of Phospholamban
(
- Contribution to journal › Article
- 2011
-
Mark
Gene expression profiling in MDS and AML: potential and future avenues.
(
- Contribution to journal › Article
-
Mark
Global microRNA analysis of the NCI-60 cancer cell panel
(
- Contribution to journal › Article
- 2010
-
Mark
A conceptual framework for the identification of candidate drugs and drug targets in acute promyelocytic leukemia
(
- Contribution to journal › Article
-
Mark
Inhibition of Human DHODH by 4-Hydroxycoumarins, Fenamic Acids, and N-(Alkylcarbonyl)anthranilic Acids Identified by Structure-Guided Fragment Selection
(
- Contribution to journal › Article
- 2008
-
Mark
A general approach to the apparent permeability index
(
- Contribution to journal › Article
- 2007
-
Mark
Quantitative detection of cell surface protein expression by time-resolved fluorimetry
(
- Contribution to journal › Article
- 2005
-
Mark
Two-photon excitation in fluorescence polarization receptor-ligand binding assay
(
- Contribution to journal › Article
- 2004
-
Mark
Compounds for deactivating phospholamban function on Ca-ATPase (phospholamban inhibitors)
2004) US 6774103 B1(
- Patent › Patent